Filings/MAB/IR

MABION S.A. IR

press release · 2026

Mabion and Oddifact have submitted a request for a meeting with the FDA regarding the development of MabionCD20 12.08.2026 Learn more

Source document

Issuer site
Loading document…
Mabion and Oddifact have submitted a request for a meeting with the FDA regarding the development of MabionCD20 12.08.2026 Learn more — MABION S.A.